ADA and hemophilia B: HSC gene therapy has been used to successfully treat monogenic diseases including adenosine deaminase deficient-severe combined immunodeficiency (ADA-SCID), X-linked SCID, X-linked adrenoleukodystrophy and hemophilia B [14].